Citius Pharmaceuticals Management
How experienced are the management team and are they aligned to shareholders interests?
2.5yrs
Average management tenure
CEO
Leonard Mazur (77 yo)
8.33yrs
Tenure
US$1,190,056
Compensation
Mr. Leonard L. Mazur has been Chief Executive Officer of Citius Pharmaceuticals, Inc. since May 01, 2022. He is a Director of Hillstream BioPharma Inc since July 2021. He has been Executive Chairman and Se...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | US$1m | US$400k | -US$34m |
| Jun 30 2022 | n/a | n/a | -US$31m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | n/a | n/a | -US$26m |
| Sep 30 2021 | US$788k | US$348k | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$24m |
| Mar 31 2021 | n/a | n/a | -US$21m |
| Dec 31 2020 | n/a | n/a | -US$21m |
| Sep 30 2020 | US$550k | US$250k | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | n/a | n/a | -US$16m |
| Sep 30 2019 | US$473k | US$250k | -US$16m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | n/a | n/a | -US$13m |
| Sep 30 2018 | US$398k | US$250k | -US$13m |
| Jun 30 2018 | n/a | n/a | -US$13m |
| Mar 31 2018 | n/a | n/a | -US$13m |
| Dec 31 2017 | n/a | n/a | -US$11m |
| Sep 30 2017 | US$307k | US$250k | -US$10m |
| Jun 30 2017 | n/a | n/a | -US$10m |
| Mar 31 2017 | n/a | n/a | -US$11m |
| Dec 31 2016 | n/a | n/a | -US$9m |
| Sep 30 2016 | US$558k | US$250k | -US$8m |
Compensation vs Market: Leonard's total compensation ($USD1.19M) is about average for companies of similar size in the US market ($USD1.65M).
Compensation vs Earnings: Leonard's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 6.83yrs | US$1.19m | 7.01% $ 14.4m | |
| Co-Founder & Executive Vice Chairman | 7.25yrs | US$1.24m | 1.36% $ 2.8m | |
| Chief Business Officer | 5.17yrs | US$809.00k | 0.041% $ 84.5k | |
| Executive VP & Chief Medical Officer | 2.5yrs | US$887.85k | 0% $ 0 | |
| Executive Vice President of Operations | 6.83yrs | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior VP & Head of Clinical Operations and Quality Assurance | 0.92yr | no data | no data | |
| Senior Vice President of Business Strategy | 2yrs | no data | no data | |
| Executive Vice President of Chemistry | 1.17yrs | no data | no data |
2.5yrs
Average Tenure
67.5yo
Average Age
Experienced Management: CTXR's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 8.33yrs | US$1.19m | 7.01% $ 14.4m | |
| Co-Founder & Executive Vice Chairman | 7.25yrs | US$1.24m | 1.36% $ 2.8m | |
| Lead Independent Director | 6.83yrs | US$229.89k | 0% $ 0 | |
| Independent Director | 7.25yrs | US$211.39k | 0% $ 0 | |
| Independent Director | 6.83yrs | US$212.89k | 0% $ 0 | |
| Independent Director | 6.83yrs | US$205.39k | 0% $ 0 | |
| Independent Director | 6.58yrs | US$205.39k | 0% $ 0 | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.5yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
6.8yrs
Average Tenure
77yo
Average Age
Experienced Board: CTXR's board of directors are considered experienced (6.8 years average tenure).